Dose reduction of ibrutinib in chronic lymphocytic leukemia: long-term outcomes from a real-world single-center experience. Mediterranean Journal of Hematology and Infectious Diseases, [S. l.], v. 18, n. 1, p. e2026090, 2026. DOI: 10.4084/MJHID.2026.090. Disponível em: https://www.mjhid.org/mjhid/article/view/6535. Acesso em: 1 nov. 2026.